Filing Details

Accession Number:
0001062993-20-004584
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-21 16:19:28
Reporting Period:
2020-09-18
Accepted Time:
2020-09-21 16:19:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
819050 Brickell Biotech Inc. BBI Biological Products, (No Disgnostic Substances) (2836) 930948554
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1758842 R. David Mcavoy C/o Brickell Biotech, Inc.
5777 Central Avenue, Suite 102
Boulder CO 80301
General Counsel And Cco No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-09-18 16,526 $0.83 75,883 No 4 P Direct
Common Stock Acquisiton 2020-09-18 6,000 $0.84 6,000 No 4 P Indirect By spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect By spouse
Footnotes
  1. Represents the purchase of 16,526 shares in multiple transactions, ranging in price from $0.8224 to $0.8429 per share, resulting in a weighted average purchase price of $0.8298. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.